News
QBTS Secures $819M Cash War Chest for Future R&D: Upside Ahead?
While D-Wave Quantum’s QBTS top line is advancing steadily, the real focus of investors is on its balance sheet. D-Wave closed the second quarter with a record $819 million in cash, up more than
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
NeuroOne Medical Technologies Corporation NMTC recently received FDA 510(k) clearance for its OneRF Trigeminal Nerve Ablation System, a minimally invasive solution for treating severe facial pain
3 Wireless Non-US Stocks Likely to Thrive Despite Industry Challenges
Eastman Kodak Stock Drops After Wider Q2 Loss, Cash Concerns Grow
Shares of Eastman Kodak Company KODK have come under significant pressure following the release of its second-quarter 2025 results. Since the earnings announcement on Aug. 11, the stock has declined
Pediatrix Medical Refills Its Buyback Prescription With $250M Dose
Pediatrix Medical Group, Inc. MD has stepped up its commitment to shareholder returns with a new $250 million share repurchase authorization, underpinned by solid cash generation. Over the past 12
Will Nebius' 1 GW Capacity Target by 2026 Accelerate Revenue Growth?
Nebius Group N.V. NBIS is positioning itself as a key player in the AI infrastructure space by setting an ambitious target of securing one gigawatt (“GW”) of capacity by 2026. Management remains
AFRM Trades at Premium: Too Much Affirm-ation, or Still Time to Buy?
Affirm Holdings, Inc. AFRM is trading like a market favorite, yet its valuation is raising eyebrows. The stock commands a forward 12-month price-to-sales (P/S) multiple of 6.26X, well above its
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is building its market opportunity around democratizing access to personalized healthcare, particularly in areas that have
nCino (NCNO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
nCino (NCNO) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook
Earnings Preview: PVH (PVH) Q2 Earnings Expected to Decline
The market expects PVH (PVH) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook is
Bank of Nova Scotia (BNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Bank of Nova Scotia (BNS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus
Best Momentum Stock to Buy for August 19th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 19th:
Century Aluminum CENX: This company which is engaged in the production of
5 ETFs That Gained Investors' Love Last Week
ETFs across various categories raked in $38 billion in capital last week, pushing year-to-date inflows to $730 billion. U.S. equity ETFs led the way with $13.3 billion in inflows, followed by $10.6
Qualcomm Just Passed 1 Major Test, But Can It Pass the Next?
After logging its best rally in more than a year, with a 35% run from April through July, Qualcomm Inc. (NASDAQ: QCOM) looked like it was about to give it all back.
A post-earnings dip in late
Westport's Q2 Loss Meets Expectations, Revenues Rise Y/Y
Westport Fuel Systems Inc. WPRT reported a loss of 29 cents per share in the second quarter of 2025, which was in line with the Zacks Consensus Estimate. The company incurred a loss of 43 cents in
Wall Street Analysts Predict a 25.38% Upside in Perpetua Resources (PPTA): Here's What You Should Know
Perpetua Resources Corp. (PPTA) closed the last trading session at $17.57, gaining 2.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts See a 178.82% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High?
Tyra Biosciences, Inc. (TYRA) closed the last trading session at $10.81, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's What You Should Know
Aligos Therapeutics, Inc. (ALGS) closed the last trading session at $8.77, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Williams-Sonoma (WSM)'s Technical Outlook is Bright After Key Golden Cross
Williams-Sonoma, Inc. (WSM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, WSM's 50-day simple moving average crossed
Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect?
DiaMedica Therapeutics, Inc. (DMAC) closed the last trading session at $5.76, gaining 26.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Think Dutch Bros (BROS) Could Surge 26.73%: Read This Before Placing a Bet
Shares of Dutch Bros (BROS) have gained 4.5% over the past four weeks to close the last trading session at $65.4, but there could still be a solid upside left in the stock if short-term price
Should You Buy LendingClub (LC) After Golden Cross?
LendingClub Corporation (LC) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, LC's 50-day simple moving average broke out above its
Sally Beauty (SBH) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Sally Beauty Holdings, Inc. (SBH) is looking like an interesting pick, as it just reached a key level of support. SBH's 50-day simple moving average crossed above its
BancFirst (BANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
The price trend for BancFirst (BANF) has been bearish lately and the stock has lost 6.1% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session


